Clinical Trials in Georgia

Showing 3621-3640 of 14,426 trials

A Study to Investigate Efficacy and Safety of VTAMA® (Tapinarof) Cream, 1% in Plaque Psoriasis in the Head and Neck Region

NCT05789576

This is an open-label, multi-center study to evaluate the efficacy and safety of VTAMA (tapinarof) cream, 1% in adults with plaque psoriasis occurring in the head and neck region

Psoriasis

Organon and Co31 participantsStarted Mar 2023

Macon, Georgia, United States • Chicago, Illinois, United States • Rockville, Maryland, United States +7 more locations

Active Not Recruiting65 miles

Biomarkers of Intestinal Fibrosis in Small Bowel Crohn's Disease

NCT04088773

This research study will evaluate if specific blood, stool and MRI tests can tell the difference between bowel wall inflammation without scarring and bowel wall inflammation with scarring that can cause bowel blockages requiring surgery.

Crohn Disease

Children's Hospital Medical Center, Cincinnati232 participantsStarted Nov 2019

Atlanta, Georgia, United States • Ann Arbor, Michigan, United States • Rochester, Minnesota, United States +1 more locations

A Study to Investigate Efficacy and Safety of VTAMA® (Tapinarof) Cream, 1% in Plaque Psoriasis in the Head and Neck Region

Biomarkers of Intestinal Fibrosis in Small Bowel Crohn's Disease

Find Trials by Condition in Georgia

Enfortumab Vedotin and Pembrolizumab vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial Cancer

Pre-oxygenation With Real Time End-tidal Oxygen Measurements Versus Single Breath Measurements

AZD3470 as Monotherapy and in Combination With Anticancer Agents in Participants With Relapsed/Refractory Haematologic Malignancies.

Improving Care Through Improv: Promoting Mastery in the Moment

A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001)

A Study to Evaluate the Efficacy and Safety of Gantenerumab in Participants at Risk for or at the Earliest Stages of Alzheimer's Disease (AD)

A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment

Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster Dose

Nemvaleukin Alfa Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cutaneous or Mucosal Melanoma - ARTISTRY-6

A Phase 1 Study of NM6603 in Advanced Solid Tumors

Natural History Study of Synucleinopathies

ProVIDE II Bridging Study

An Evaluation of the Safety of CSF-1 in Presbyopic Subjects

A Study to Investigate Efficacy and Safety of VTAMA (Tapinarof) Cream, 1% in Intertriginous Plaque Psoriasis

A Study to Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease

AVID100 in Advanced Epithelial Carcinomas

Study of Neoadjuvant Olaparib Monotherapy and Olaparib and Durvalumab Combination in HER2 Negative BRCAm Breast Cancer